Osiris Therapeutics, Inc.
Records under this name other than the patents Osiris Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 33 patents it holds.
Back to Osiris Therapeutics, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,486,695 | Mesenchymal Stem Cells Expressing TNF-alpha Receptors now held by Mesoblast International Sàrl In force · High confidence | In force | High confidence | |
| US 8,460,860 | Cancellous bone treated with collagenase and essentially free of blood cells now held by NuVasive, Inc. In force · High confidence | In force | High confidence | |
| US 8,637,004 | Purified Mesenchymal Stem Cell Compositions and Methods of Purifying Mesenchymal Stem Cell Compositions now held by Mesoblast International Sàrl In force · High confidence | In force | High confidence | |
| US 9,050,178 | Joint Repair Using Mesenchymal Stem Cells now held by Mesoblast International Sàrl Term ended Term ended Apr 24, 2021 · Medium confidence | Term ended | Term ended Apr 24, 2021 | Medium confidence |
| US 9,814,580 | Joint Repair Using Mesenchymal Stem Cells now held by Mesoblast International Sàrl Term ended Term ended Apr 24, 2021 · Medium confidence | Term ended | Term ended Apr 24, 2021 | Medium confidence |
| US 7,514,074 | Cardiac Muscle Regeneration Using Mesenchymal Stem Cells now held by Mesoblast International Sàrl Term ended Ended no later than Jun 23, 2020 · Low confidence | Term ended | Ended no later than Jun 23, 2020 | Low confidence |
| US 7,153,500 | Production of Megakaryocytes by the Use of Human Mesenchymal Stem Cells held by Mesoblast International Sàrl Term ended Term ended Jan 29, 2020 · Medium confidence | Term ended | Term ended Jan 29, 2020 | Medium confidence |
| US 6,761,887 | Alginate Layer System for Chondrogenic Differentiation of Human Mesenchymal Stem Cells now held by Mesoblast International Sàrl Term ended Term ended Nov 16, 2019 · High confidence | Term ended | Term ended Nov 16, 2019 | High confidence |
| US 7,491,388 | Uses of Fibroblasts or Supernatants from Fibroblasts for the Suppression of Immune Responses in Transplantation now held by Mesoblast International Sàrl Term ended Term ended Nov 4, 2019 · High confidence | Term ended | Term ended Nov 4, 2019 | High confidence |
| US 7,892,829 | Cardiac Muscle Regeneration Using Mesenchymal Stem Cells now held by Mesoblast International Sàrl Term ended Term ended Jul 14, 2018 · Medium confidence | Term ended | Term ended Jul 14, 2018 | Medium confidence |